Tissue engineered products (TEPs), which mean biomaterials containing either cells or
growth factors or both cells and growth factors, may be used as an alternative to the …

It has always been an ambitious goal in medicine to repair or replace morbid tissues for
regaining the organ functionality. This challenge has recently gained momentum through …

Background Adipose-derived stem cells (ASCs) have been introduced as an alternative to
bone marrow mesenchymal stem cells (BMSCs) for cell-based therapy. However, different …

Mesenchymal (stromal) stem cells (MSCs) constitute populations of mesodermal multipotent
cells involved in tissue regeneration and homeostasis in many different organs. Here we …

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is an
inflammatory condition that results in gastrointestinal tract damage. Various factors …

Bone tissue engineering (BTE) is now a promising research issue to improve the drawbacks
from traditional bone grafting procedure such as limited donor sources and possible …

Mesenchymal stem cells (MSCs) hold promise for cell-based therapy in regenerative
medicine. To date, MSCs have been obtained from conventional bone marrow via a highly …

Bone marrow (BM) microenvironment represents an important compartment of bone that
regulates bone homeostasis and the balance between bone formation and bone resorption …

MicroRNAs (miRNAs) emerge as important regulators of stem cell lineage commitment and
bone development. MiRNA-26a (miR-26a) is one of the important miRNAs regulating …

Orthopedic implants rely on facilitating a robust interaction between the implant material
surface and the surrounding bone tissue. Ideally, the interface will encourage …